Effects of luseogliflozin on arterial properties in patients with type 2 diabetes mellitus: The multicenter, exploratory LUSCAR study

Sodium‐glucose cotransporter 2 (SGLT2) inhibitors reduce the occurrence of cardiovascular and renal complications in patients with type 2 diabetes mellitus (T2DM) and represent guideline‐recommended therapy in this indication. However, precise mechanisms underlying the beneficial cardiovascular effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kario, Kazuomi, Okada, Kenta, Murata, Mitsunobu, Suzuki, Daisuke, Yamagiwa, Kayo, Abe, Yasuhisa, Usui, Isao, Tsuchiya, Norihiro, Iwashita, Chie, Harada, Noriko, Okawara, Yukie, Ishibashi, Shun, Hoshide, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Sglt2 Inhibition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590106/
https://www.ncbi.nlm.nih.gov/pubmed/32810338
http://dx.doi.org/10.1111/jch.13988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590106/
https://www.ncbi.nlm.nih.gov/pubmed/32810338
http://dx.doi.org/10.1111/jch.13988

Ejemplares similares